Treating Inflammatory Bowel Disease During Pregnancy: Risks and Safety of Drug Therapy

ISSN： 0114-5916

Source： Drug Safety, Vol.21, Iss.4, 1999-10, pp. : 311-323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease

By Saha Sumona Wald Arnold

Expert Opinion on Drug Safety, Vol. 11, Iss. 6, 2012-11 ,pp. : 947-957

Informa Healthcare

Access to resources Recommend Favorite

Anti-TNF Antibody Therapy for Inflammatory Bowel Disease During Pregnancy: A Clinical Review

Current Drug Targets, Vol. 11, Iss. 2, 2010-02 ,pp. : 234-241

Bentham Science Publishers

Access to resources Recommend Favorite

Optimization of Drug Safety Profile in Inflammatory Bowel Disease Through a Personalized Approach

Current Drug Targets, Vol. 19, Iss. 7, 2018-04 ,pp. : 740-747

Bentham Science Publishers

Access to resources Recommend Favorite

The use of medications for inflammatory bowel disease during pregnancy and nursing

By Sauk Jenny Kane Sunanda

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. : 1833-1839

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease and Established Azathioprine Therapy

By L.P.L. Gilissen

Clinical Drug Investigation, Vol. 24, Iss. 8, 2004-01 ,pp. : 479-486

Adis International

Access to resources Recommend Favorite